rs1185193

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000224140.6(SETX):ā€‹c.3576T>Gā€‹(p.Asp1192Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.818 in 1,613,658 control chromosomes in the GnomAD database, including 550,679 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.77 ( 46132 hom., cov: 31)
Exomes š‘“: 0.82 ( 504547 hom. )

Consequence

SETX
ENST00000224140.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: -1.15
Variant links:
Genes affected
SETX (HGNC:445): (senataxin) This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.1617526E-7).
BP6
Variant 9-132328022-A-C is Benign according to our data. Variant chr9-132328022-A-C is described in ClinVar as [Benign]. Clinvar id is 95661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132328022-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.854 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SETXNM_015046.7 linkuse as main transcriptc.3576T>G p.Asp1192Glu missense_variant 10/26 ENST00000224140.6 NP_055861.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SETXENST00000224140.6 linkuse as main transcriptc.3576T>G p.Asp1192Glu missense_variant 10/261 NM_015046.7 ENSP00000224140 P1Q7Z333-1

Frequencies

GnomAD3 genomes
AF:
0.768
AC:
116730
AN:
151978
Hom.:
46110
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.643
Gnomad AMI
AF:
0.875
Gnomad AMR
AF:
0.817
Gnomad ASJ
AF:
0.768
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.636
Gnomad FIN
AF:
0.858
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.860
Gnomad OTH
AF:
0.788
GnomAD3 exomes
AF:
0.768
AC:
192797
AN:
251086
Hom.:
76930
AF XY:
0.768
AC XY:
104256
AN XY:
135734
show subpopulations
Gnomad AFR exome
AF:
0.642
Gnomad AMR exome
AF:
0.812
Gnomad ASJ exome
AF:
0.783
Gnomad EAS exome
AF:
0.313
Gnomad SAS exome
AF:
0.654
Gnomad FIN exome
AF:
0.857
Gnomad NFE exome
AF:
0.857
Gnomad OTH exome
AF:
0.800
GnomAD4 exome
AF:
0.823
AC:
1203440
AN:
1461562
Hom.:
504547
Cov.:
58
AF XY:
0.819
AC XY:
595396
AN XY:
727076
show subpopulations
Gnomad4 AFR exome
AF:
0.631
Gnomad4 AMR exome
AF:
0.813
Gnomad4 ASJ exome
AF:
0.781
Gnomad4 EAS exome
AF:
0.295
Gnomad4 SAS exome
AF:
0.656
Gnomad4 FIN exome
AF:
0.856
Gnomad4 NFE exome
AF:
0.864
Gnomad4 OTH exome
AF:
0.787
GnomAD4 genome
AF:
0.768
AC:
116803
AN:
152096
Hom.:
46132
Cov.:
31
AF XY:
0.763
AC XY:
56734
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.643
Gnomad4 AMR
AF:
0.817
Gnomad4 ASJ
AF:
0.768
Gnomad4 EAS
AF:
0.331
Gnomad4 SAS
AF:
0.636
Gnomad4 FIN
AF:
0.858
Gnomad4 NFE
AF:
0.860
Gnomad4 OTH
AF:
0.786
Alfa
AF:
0.826
Hom.:
125056
Bravo
AF:
0.758
TwinsUK
AF:
0.866
AC:
3211
ALSPAC
AF:
0.856
AC:
3299
ESP6500AA
AF:
0.659
AC:
2902
ESP6500EA
AF:
0.862
AC:
7411
ExAC
AF:
0.763
AC:
92682
Asia WGS
AF:
0.516
AC:
1796
AN:
3478
EpiCase
AF:
0.856
EpiControl
AF:
0.849

ClinVar

Significance: Benign
Submissions summary: Benign:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:10
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxMar 20, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 24, 2013- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, 2 labs classify as benign/LB in clinvar -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 12, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Amyotrophic lateral sclerosis type 4 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
0.0010
DANN
Benign
0.74
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.094
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
8.2e-7
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.90
L
MutationTaster
Benign
1.0
P;P;P
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.64
N
REVEL
Benign
0.27
Sift
Benign
0.38
T
Sift4G
Benign
0.46
T
Polyphen
0.0010
B
Vest4
0.010
MutPred
0.049
Gain of methylation at K1190 (P = 0.0802);
MPC
0.070
ClinPred
0.020
T
GERP RS
-9.5
Varity_R
0.071
gMVP
0.060

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1185193; hg19: chr9-135203409; COSMIC: COSV56383702; API